Metraipolis › archive › dc_63f01db1fadd
Systematic bioinformatics analysis identifies shikonin as a novel mTOR pathway inhibitor in triple-negative breast cancer progression — Europe PMC PMID:40949144
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40949144
- DOI
- 10.3389/fphar.2025.1603093
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T06:45:11.983Z
- SHA-256 of the archived text
74fb2707da94daa0b6e5c4ecc2c33abd0d25da287d2cdf262665bb7fd75283ea- Stable URL of this page
https://metraipolis.com/documento/dc_63f01db1fadd
How to cite
Systematic bioinformatics analysis identifies shikonin as a novel mTOR pathway inhibitor in triple-negative breast cancer progression — Europe PMC PMID:40949144 — Europe PMC (en), https://europepmc.org/article/MED/40949144 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_63f01db1fadd (Metraipolis archive dc_63f01db1fadd, sha256 74fb2707da94daa0b6e5c4ecc2c33abd0d25da287d2cdf262665bb7fd75283ea)
BibTeX
@misc{dc63f01db1fadd,
title = {Systematic bioinformatics analysis identifies shikonin as a novel mTOR pathway inhibitor in triple-negative breast cancer progression — Europe PMC PMID:40949144},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40949144},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_63f01db1fadd; sha256 74fb2707da94daa0b6e5c4ecc2c33abd0d25da287d2cdf262665bb7fd75283ea},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40949144. Agents can read the archived copy with the MCP tool read_document.